What is the Recommended Dosage of Ozempic for Weight Loss?

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has revolutionized weight loss treatment with clinical trials showing 15–22% body weight reduction over 68 weeks. Unlike fixed-dose medications, semaglutide requires careful dose escalation to maximize results while minimizing side effects. Understanding how dosing works and why personalization matters can help you achieve sustainable weight loss with PlexusDx.

How Semaglutide Dosing Works for Weight Loss

Semaglutide dosing follows a structured titration protocol designed to help your body adapt to the medication while reaching an effective therapeutic level. The standard approach begins at 0.25 mg once weekly, a dose low enough to allow your digestive system time to acclimate. Over the following four weeks, your body responds to this initial dose by reducing hunger signals and improving blood sugar control—the foundation for sustainable weight loss.

Every four weeks, your dose typically increases by 0.25 mg increments (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) until you reach a maintenance dose that balances effectiveness with tolerability. Clinical data shows that most people achieve meaningful weight loss results somewhere in this range, though the ideal dose varies based on individual metabolism, gastrointestinal tolerance, and genetic factors. PlexusDx clinicians monitor your response throughout this escalation to ensure you're progressing safely.

Standard Semaglutide Dose Titration Schedule

The FDA-studied titration schedule for weight loss divides treatment into phases that give your system time to adjust. Weeks 1–4 involve a 0.25 mg weekly injection, establishing baseline tolerance and initial appetite suppression. This conservative start reduces the likelihood of nausea, vomiting, or diarrhea that some patients experience when doses escalate too quickly.

Weeks 5–8 move to 0.5 mg weekly, a doubling that typically coincides with noticeable appetite reduction and early weight loss. Weeks 9–12 increase to 1.0 mg, where most patients report meaningful satiety changes and sustained weight decline. The progression continues through 1.7 mg and potentially 2.4 mg maintenance doses, with each level held for at least four weeks to assess your individual response before advancing. PlexusDx provides clear injection guidance and side-effect tracking at every stage of your titration journey.

Why Individual Dosing Varies and Matters

No two bodies metabolize semaglutide identically—genetics, liver function, stomach sensitivity, and baseline weight all influence how quickly you can escalate and where your optimal dose sits. Some patients reach excellent results at 1.0 mg weekly, while others require 2.4 mg or may benefit from combination therapy. Rushing through dose increases or pushing beyond your body's tolerance window often leads to medication discontinuation, defeating the weight loss goal.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Semaglutide Maintenance Dose and Long-Term Use

Once you reach a dose level where appetite suppression is adequate and side effects are minimal, you enter the maintenance phase. For most weight loss patients, this stabilizes between 1.7 mg and 2.4 mg weekly, though some achieve their goals at lower doses. Maintenance means continuing that same weekly injection dose indefinitely (or as long as weight loss remains a goal), with periodic check-ins to assess hunger levels, gastrointestinal comfort, and progress toward your target weight.

Long-term semaglutide therapy requires consistent adherence because stopping the medication typically leads to weight regain within weeks as appetite hormones rebound. PlexusDx makes maintenance straightforward by shipping your weekly injections on a predictable schedule and maintaining flat monthly pricing throughout your treatment journey—no surprise increases as your dose stabilizes. Regular communication with your PlexusDx clinician ensures your maintenance dose continues matching your evolving health goals and metabolic needs.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?

The standard starting dose is 0.25 mg injected once weekly, a low dose designed to allow your body to adapt before escalating. This conservative approach helps minimize nausea and gastrointestinal side effects while establishing your baseline tolerance. PlexusDx clinicians guide you through this initial phase with clear injection instructions and side-effect monitoring.

How quickly should semaglutide doses increase?

Doses increase by 0.25 mg every four weeks (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) following the standard titration schedule studied in clinical trials. This four-week interval allows your digestive system and hunger signals to adapt before the next increase. Some patients may benefit from slower escalation if they experience significant side effects; PlexusDx clinicians adjust your timeline based on your individual response.

Can I stay on a lower semaglutide dose if it's working for me?

Absolutely. If 0.5 mg, 1.0 mg, or 1.7 mg produces the appetite suppression and weight loss you want with tolerable side effects, there's no clinical requirement to continue escalating. Your maintenance dose should match your individual needs and comfort level. PlexusDx charges a flat monthly rate regardless of which dose you ultimately use, so you're never penalized for staying at a lower effective level.

What happens if semaglutide side effects become severe during dose escalation?

Nausea, vomiting, constipation, or diarrhea occasionally occur, especially during the first few weeks or after dose increases. Slowing your titration schedule, taking injections at night, staying well-hydrated, and adjusting your diet composition often resolve these issues without stopping medication. If side effects persist, PlexusDx clinicians can pause escalation, extend the timeline between dose increases, or explore alternative compounds like oral semaglutide or tirzepatide to find a better match.

How does the Precision Peptide Genetic Test help with semaglutide dosing?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Glp 1 Dosage For Weight Loss
• Weight Loss Drugs Like Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.